{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:59:44Z","timestamp":1774418384387,"version":"3.50.1"},"reference-count":44,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,1,5]]},"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>We report an extremely rare case of adult Langerhans cell histiocytosis (LCH) in a patient with papillary thyroid carcinoma (PTC) and Castleman disease (CD). A 46-year-old man visited our hospital with anaemia; systemic imaging showed an abdominal and a left thyroid mass. Biopsy confirmed CD for the abdominal mass and PTC for the thyroid mass. Two months after, he presented with headache and a right parietal lump. Brain CT and enhanced MRI revealed an osteolytic mass with enhancement in the right parietal skull. Surgical removal and biopsy confirmed the diagnosis of skull LCH. The BRAF mutation was positive on PTC and negative on CD and LCH. We conducted surgical resection only for PTC and LCH; surgical resection with siltuximab for multicentric CD. At the 25-month follow-up, there was no recurrence or progression. We may consider of syndromic nature of these diseases to establish a treatment strategy.<\/jats:p>","DOI":"10.1136\/bcr-2020-239341","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T11:47:21Z","timestamp":1611575241000},"page":"e239341","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Adult Langerhans cell histiocytosis of skull in a patient with synchronous papillary thyroid carcinoma and Castleman disease"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7761-9456","authenticated-orcid":false,"given":"In Kyeong","family":"Kim","sequence":"first","affiliation":[{"name":"Neurosurgery, Kangwon National University Hospital, Chuncheon, Kangwondo, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Yul","family":"Lee","sequence":"additional","affiliation":[{"name":"Pathology, Kangwon National University Hospital, Chuncheon, Kangwondo, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"2025082700162118000_14.1.e239341.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2006.00648.x"},{"key":"2025082700162118000_14.1.e239341.2","doi-asserted-by":"crossref","unstructured":"Favara BE , Feller AC , Pauli M . Contemporary classification of histiocytic disorders. The who Committee on Histiocytic\/Reticulum cell proliferations. .Med Pediatr Oncol 1997.","DOI":"10.1002\/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C"},{"key":"2025082700162118000_14.1.e239341.3","doi-asserted-by":"crossref","unstructured":"Kim SS , Hong SA , Shin HC . Adult Langerhans\u2019 cell histiocytosis with multisystem involvement A case report. Med 2018;97.","DOI":"10.1097\/MD.0000000000013366"},{"key":"2025082700162118000_14.1.e239341.4","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13439"},{"key":"2025082700162118000_14.1.e239341.5","first-page":"5","article-title":"Langerhans cell histiocytosis of the thyroid complicated by papillary thyroid carcinoma","volume":"96","author":"Wu","year":"2017","journal-title":"Medicine"},{"key":"2025082700162118000_14.1.e239341.6","doi-asserted-by":"crossref","DOI":"10.16956\/jes.2017.17.4.175","article-title":"The clinical significance of the BRAF mutation in patients with papillary thyroid cancer","volume":"17","author":"Kim","year":"2017","journal-title":"J Endocr Surg"},{"key":"2025082700162118000_14.1.e239341.7","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318148563d"},{"key":"2025082700162118000_14.1.e239341.8","article-title":"Epidemiology of thyroid cancer: a review of the National cancer database, 2000-2013","volume":"11","author":"Olson","year":"2019","journal-title":"Cureus"},{"key":"2025082700162118000_14.1.e239341.9","unstructured":"Edition S . AJCC cancer staging manual. AJCC cancer staging manual, 2017."},{"key":"2025082700162118000_14.1.e239341.10","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-72"},{"key":"2025082700162118000_14.1.e239341.11","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2003.1110202.x"},{"key":"2025082700162118000_14.1.e239341.12","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4"},{"key":"2025082700162118000_14.1.e239341.13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.37029\/jcas.v4i4.209","article-title":"Castleman disease: a great MIMICKER of metastases in radioiodine refractory thyroid cancer","volume":"4","author":"Rashid","year":"2018","journal-title":"J Cancer Allied Spec"},{"key":"2025082700162118000_14.1.e239341.14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/567840","article-title":"Multicentric Castleman\u2019s Disease in a Hepatitis C-Positive Intravenous Drug User: A Case Report","volume":"2011","author":"Talukder","year":"2011","journal-title":"Case Rep Med"},{"key":"2025082700162118000_14.1.e239341.15","doi-asserted-by":"publisher","DOI":"10.1177\/1066896909341803"},{"key":"2025082700162118000_14.1.e239341.16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00431-004-1493-y","article-title":"Identical twin brothers concordant for Langerhans? cell histiocytosis and discordant for Epstein-Barr virus-associated haemophagocytic syndrome","volume":"163","author":"Chen","year":"2004","journal-title":"Eur J Pediatr"},{"key":"2025082700162118000_14.1.e239341.17","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1002\/jcp.27144","article-title":"Epstein-Barr virus and thyroid cancer: the role of viral expressed proteins","volume":"234","author":"Moghoofei","year":"2019","journal-title":"J Cell Physiol"},{"key":"2025082700162118000_14.1.e239341.18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.prp.2017.01.020","article-title":"Evaluation of the presence of Epstein-Barr virus (EBV) in Iranian patients with thyroid papillary carcinoma","volume":"213","author":"Homayouni","year":"2017","journal-title":"Pathol Res Pract"},{"key":"2025082700162118000_14.1.e239341.19","first-page":"486","article-title":"Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy","volume":"8","author":"van Rhee","year":"2010","journal-title":"Clin Adv Hematol Oncol"},{"key":"2025082700162118000_14.1.e239341.20","first-page":"550","article-title":"An\u00e1lisis histopatol\u00f3gico E inmunohistoqu\u00edmico de treinta Y nueve casos","volume":"153","author":"Sevilla-Lizcano","year":"2017","journal-title":"Gac Med Mex"},{"key":"2025082700162118000_14.1.e239341.21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12020-015-0652-4","article-title":"Castleman disease mimicking nodal recurrence of thyroid cancer","volume":"51","author":"Zeng","year":"2016","journal-title":"Endocrine"},{"key":"2025082700162118000_14.1.e239341.22","first-page":"192","article-title":"Castleman disease. A report of six cases","volume":"87","author":"Fetica","year":"2014","journal-title":"Clujul Med"},{"key":"2025082700162118000_14.1.e239341.23","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-200194050-00004"},{"key":"2025082700162118000_14.1.e239341.24","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.1985.3.9.1202","article-title":"A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients","volume":"3","author":"Frizzera","year":"1985","journal-title":"J Clin Oncol"},{"key":"2025082700162118000_14.1.e239341.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1989.tb02162.x"},{"key":"2025082700162118000_14.1.e239341.26","first-page":"422","article-title":"Thyromegaly secondary to simultaneous papillary carcinoma and histiocytosis X. Report of a case and review of the literature","volume":"35","author":"Goldstein","year":"1991","journal-title":"Acta Cytol"},{"key":"2025082700162118000_14.1.e239341.27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00176706","article-title":"Langerhans cell histiocytosis isolated to the thyroid gland","volume":"253","author":"Thompson","year":"1996","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2025082700162118000_14.1.e239341.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1092-9134(00)90006-6"},{"key":"2025082700162118000_14.1.e239341.29","doi-asserted-by":"publisher","DOI":"10.1385\/EP:13:3:227"},{"key":"2025082700162118000_14.1.e239341.30","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pbc.21030","article-title":"Thyroid involvement with Langerhans cell histiocytosis in a 3-year-old male","volume":"50","author":"Burnett","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"2025082700162118000_14.1.e239341.31","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-009-9068-0"},{"key":"2025082700162118000_14.1.e239341.32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12022-010-9134-7","article-title":"Langerhans cell histiocytosis of the thyroid is a rare entity, but an association with a papillary thyroid carcinoma is often described","volume":"21","author":"Vergez","year":"2010","journal-title":"Endocr Pathol"},{"key":"2025082700162118000_14.1.e239341.33","doi-asserted-by":"crossref","DOI":"10.3803\/EnM.2012.27.2.138","article-title":"Langerhans cell histiocytosis in the thyroid and draining lymph nodes: a case report","volume":"27","author":"Chung","year":"2012","journal-title":"Endocrinol Metab"},{"key":"2025082700162118000_14.1.e239341.34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/184237","article-title":"Langerhans cell histiocytosis of the thyroid with multiple cervical lymph node involvement accompanying metastatic thyroid papillary carcinoma","volume":"2014","author":"Ceyran","year":"2014","journal-title":"Case Rep Pathol"},{"key":"2025082700162118000_14.1.e239341.35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pbc.25173","article-title":"Synchronous and metachronous thyroid cancer in relation to Langerhans cell histiocytosis; involvement of V600E BRAF-mutation?","volume":"62","author":"Moschovi","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"2025082700162118000_14.1.e239341.36","first-page":"1","article-title":"Occult Langerhans cell histiocytosis presenting with papillary thyroid carcinoma, a thickened pituitary stalk and diabetes insipidus","volume":"2016","author":"Gordon","year":"2016","journal-title":"Case Rep Endocrinol"},{"key":"2025082700162118000_14.1.e239341.37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.21037\/gs.2016.09.03","article-title":"Thyroid Langerhans cell histiocytosis and papillary thyroid carcinoma","volume":"5","author":"AlZahrani","year":"2016","journal-title":"Gland Surg"},{"key":"2025082700162118000_14.1.e239341.38","first-page":"5","article-title":"Langerhans cell histiocytosis co-existing with papillary carcinoma of thyroid \u2013 a rare surgical challenge","volume":"4","author":"Bakshi","year":"2018","journal-title":"ARC J Cancer Sci"},{"key":"2025082700162118000_14.1.e239341.39","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-0195985-6"},{"key":"2025082700162118000_14.1.e239341.40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9508"},{"key":"2025082700162118000_14.1.e239341.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(03)00672-5"},{"key":"2025082700162118000_14.1.e239341.42","first-page":"22246","article-title":"The BRAF V600E mutation predicts poor survival outcome in patients with papillary thyroid carcinoma: a meta analysis","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2025082700162118000_14.1.e239341.43","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0075"},{"key":"2025082700162118000_14.1.e239341.44","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2018.180547","article-title":"A case of unicentric Castleman disease and Langerhans cell histiocytosis: two entities in one lymph node","volume":"64","author":"Liu","year":"2018","journal-title":"Clin Lab"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-239341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:16:34Z","timestamp":1756278994000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-239341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,25]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/bcr-2020-239341"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-239341","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}